Ecallantide
Ecallantide is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Kalbitor. Available dosage form: injection, solution.
Drug Details
- Generic Name
- Ecallantide
- Brand Names
- Kalbitor
- Application Number
- BLA125277
- Sponsor
- Takeda Pharmaceuticals America, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- ECALLANTIDE
Indications and Usage
1 INDICATIONS AND USAGE KALBITOR ® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older. KALBITOR is a plasma kallikrein inhibitor indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older. ( 1 )